Episode
Episode 1: The End of Wet Labs? How Digital is Virtualizing Pharma Research
- Podcast
- Hypothesize That!
- Published
- Apr 14, 2025
- Duration seconds
- 1700
- Processing state
not_requested- Canonical source
- https://shows.acast.com/hypothesize-that/episodes/the-end-of-wet-labs-how-digital-is-virtualizing-pharma-resea
Actions
POST https://stenobird.com/v1/public/podcasts/hypothesize-that-7842584/episodes/episode-1-the-end-of-wet-labs-how-digital-is-virtualizing-pharma-research/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hypothesize-that-7842584/episode-1-the-end-of-wet-labs-how-digital-is-virtualizing-pharma-research.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we tackle a transformative question: will traditional wet labs be rendered obsolete by digital and AI-powered innovations? Host Nicola Hill is joined by Professor Russ Altman from Stanford University, and Dr. Alistair Henry, UCB’s Chief Scientific Officer, to debate the rise of virtual pharmaceutical research. Discover how technologies like machine learning, in silico compound screening, and digital twins are redefining drug discovery. From unprecedented advancements to persistent challenges, our experts dissect whether digital simulations can truly replicate—and surpass—the capabilities of physical labs. Will a hybrid model of digital and traditional methods shape the future of pharma research? This podcast is produced and funded by UCB. Hosted on Acast. See acast.com/privacy for more information. Hosted on Acast. See acast.com/privacy for more information.